{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T05:11:13Z","timestamp":1766725873788,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, Portugal"},{"name":"Medical Research Council, United Kingdom"},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Knowledge about the distribution and frequency of the respective haplotypes on the wildtype and mutant allele is highly relevant in the context of future gene therapy clinical studies in Spinocerebellar Ataxia Type 3, the most common autosomal dominantly inherited ataxia. Single nucleotide polymorphisms associated to the disease-causing gene,\n                      <jats:italic>ATXN3<\/jats:italic>\n                      , have been determined. We wanted to investigate the frequency and regional distribution of two intragenic single nucleotide polymorphisms (SNPs) in a large European SCA3 cohort and their relation to the clinical phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The genotypes of the two polymorphisms at base pair positions 987 and 1118 of the\n                      <jats:italic>ATXN3<\/jats:italic>\n                      were determined for their co-localization on the normal and expanded allele, respectively, in 286 SCA3 mutation carriers and 117 healthy controls from 11 European sites.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The distribution of genotypes on the expanded allele differed from those of the wildtype allele of SCA3 mutation carriers and of healthy controls, and was mainly influenced by the regional origin. In our cohort, no particular clinical phenotype was associated with any specific haplotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results confirm distinct allocations of SNPs associated to the expanded\n                      <jats:italic>ATXN3<\/jats:italic>\n                      , and accordingly the consideration of allele-specific therapies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-024-12829-9","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:29:13Z","timestamp":1733988553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7282-1012","authenticated-orcid":false,"given":"Tim Lukas","family":"Elter","sequence":"first","affiliation":[]},{"given":"Daniel","family":"Sturm","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-7516","authenticated-orcid":false,"given":"Magda M.","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Tamara","family":"Schaprian","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6899-0352","authenticated-orcid":false,"given":"Mafalda","family":"Raposo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1759-762X","authenticated-orcid":false,"given":"Ana Rosa Vieira","family":"Melo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-3273","authenticated-orcid":false,"given":"Manuela","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Berkan","family":"Koyak","sequence":"additional","affiliation":[]},{"given":"Demet","family":"Oender","sequence":"additional","affiliation":[]},{"given":"Marcus","family":"Grobe-Einsler","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-8949","authenticated-orcid":false,"given":"Patrick","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds Pereira","family":"de Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-4788","authenticated-orcid":false,"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Garcia-Moreno","sequence":"additional","affiliation":[]},{"given":"Suran","family":"Nethisinhe","sequence":"additional","affiliation":[]},{"given":"Jeroen","family":"de Vries","sequence":"additional","affiliation":[]},{"given":"Bart P.","family":"van de Warrenburg","sequence":"additional","affiliation":[]},{"given":"Judith","family":"van Gaalen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-7273","authenticated-orcid":false,"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7774-5025","authenticated-orcid":false,"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9730-9228","authenticated-orcid":false,"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[]},{"given":"Friedrich","family":"Erdlenbruch","sequence":"additional","affiliation":[]},{"given":"Heike","family":"Jacobi","sequence":"additional","affiliation":[]},{"given":"Jon","family":"Infante","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7011-1369","authenticated-orcid":false,"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Klockgether","sequence":"additional","affiliation":[]},{"name":"ESMI study group","sequence":"additional","affiliation":[]},{"given":"Dagmar","family":"Timmann","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Thieme","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-0262","authenticated-orcid":false,"given":"Jennifer","family":"Faber","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-0923","authenticated-orcid":false,"given":"Jeannette","family":"H\u00fcbener-Schmid","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"1","key":"12829_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5(1):24","journal-title":"Nat Rev Dis Primers"},{"key":"12829_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-6-35","volume":"6","author":"C Bettencourt","year":"2011","unstructured":"Bettencourt C, Lima M (2011) Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis 6:35","journal-title":"Orphanet J Rare Dis"},{"key":"12829_CR3","first-page":"1","volume":"1","author":"M Araujo","year":"2016","unstructured":"Araujo M, Raposo M, Kazachkova N, Vasconcelos J, Kay T, Lima M (2016) Trends in the epidemiology of spinocerebellar ataxia type 3\/machado-joseph disease in the azores islands. Portugal JSM Brain Science 1:1\u20135","journal-title":"Portugal JSM Brain Science"},{"issue":"2","key":"12829_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.ejhg.5200264","volume":"7","author":"P Maciel","year":"1999","unstructured":"Maciel P, Gaspar C, Guimar\u00e3es L, Goto J, Lopes-Cendes I, Hayes S et al (1999) Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract. Eur J Hum Genet 7(2):147\u2013156","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"12829_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s100380170060","volume":"46","author":"Y Ichikawa","year":"2001","unstructured":"Ichikawa Y, Goto J, Hattori M, Toyoda A, Ishii K, Jeong SY et al (2001) The genomic structure and expression of MJD, the Machado-Joseph disease gene. J Hum Genet 46(7):413\u2013422","journal-title":"J Hum Genet"},{"issue":"3","key":"12829_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ng0793-300","volume":"4","author":"Y Takiyama","year":"1993","unstructured":"Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y et al (1993) The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet 4(3):300\u2013304","journal-title":"Nat Genet"},{"issue":"10","key":"12829_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, \u00d6z G, Paulson HL (2018) Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol 14(10):590\u2013605","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"12829_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/ejhg.2010.10","volume":"18","author":"J Sequeiros","year":"2010","unstructured":"Sequeiros J, Seneca S, Martindale J (2010) Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias. Eur J Hum Genet 18(11):1188\u20131195","journal-title":"Eur J Hum Genet"},{"key":"12829_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104635","volume":"134","author":"HS McLoughlin","year":"2020","unstructured":"McLoughlin HS, Moore LR, Paulson HL (2020) Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol Dis 134:104635","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"12829_CR10","first-page":"69","volume":"13","author":"U Wullner","year":"1998","unstructured":"Wullner U, Evert B, Klockgether T (1998) Mechanisms of cell death in cerebellar disorders. Restor Neurol Neurosci 13(1\u20132):69\u201373","journal-title":"Restor Neurol Neurosci"},{"issue":"4","key":"12829_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13311-019-00798-1","volume":"16","author":"JD Da Silva","year":"2019","unstructured":"Da Silva JD, Teixeira-Castro A, Maciel P (2019) From pathogenesis to novel therapeutics for spinocerebellar ataxia type 3: evading potholes on the way to translation. Neurotherapeutics 16(4):1009\u20131031","journal-title":"Neurotherapeutics"},{"key":"12829_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.omtn.2021.11.015","volume":"27","author":"S Hauser","year":"2022","unstructured":"Hauser S, Helm J, Kraft M, Korneck M, H\u00fcbener-Schmid J, Sch\u00f6ls L (2022) Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Mol Ther Nucleic Acids 27:99\u2013108","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"12829_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ana.26713","volume":"94","author":"HS McLoughlin","year":"2023","unstructured":"McLoughlin HS, Gundry K, Rainwater O, Schuster KH, Wellik IG, Zalon AJ et al (2023) Antisense oligonucleotide silencing reverses abnormal neurochemistry in spinocerebellar ataxia 3 mice. Ann Neurol 94(4):658\u2013671","journal-title":"Ann Neurol"},{"issue":"1","key":"12829_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","volume":"84","author":"HS McLoughlin","year":"2018","unstructured":"McLoughlin HS, Moore LR, Chopra R, Komlo R, McKenzie M, Blumenstein KG et al (2018) Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Ann Neurol 84(1):64\u201377","journal-title":"Ann Neurol"},{"key":"12829_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.omtm.2019.10.008","volume":"15","author":"R Martier","year":"2019","unstructured":"Martier R, Sogorb-Gonzalez M, Stricker-Shaver J, H\u00fcbener-Schmid J, Keskin S, Klima J et al (2019) Development of an AAV-based microRNA gene therapy to treat Machado-Joseph disease. Mol Ther Methods Clin Dev 15:343\u2013358","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"12","key":"12829_CR16","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL et al (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100(12):7195\u20137200","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"12829_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052396","volume":"8","author":"C N\u00f3brega","year":"2013","unstructured":"N\u00f3brega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, D\u00e9glon N et al (2013) Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS\u00a0One 8(1):e52396","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"12829_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117488","volume":"10","author":"Z Long","year":"2015","unstructured":"Long Z, Chen Z, Wang C, Huang F, Peng H, Hou X et al (2015) Two novel SNPs in ATXN3 3\u2032 UTR may decrease age at onset of SCA3\/MJD in Chinese patients. PLoS\u00a0One 10(2):e0117488","journal-title":"PLoS\u00a0One"},{"issue":"44","key":"12829_CR19","doi-asserted-by":"publisher","first-page":"27321","DOI":"10.18632\/oncotarget.24535","volume":"9","author":"XZ Wang","year":"2018","unstructured":"Wang XZ, Huang XY, Yao JG, Wang C, Xia Q, Long XD (2018) Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. Oncotarget 9(44):27321\u201327332","journal-title":"Oncotarget"},{"issue":"4","key":"12829_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/JASI.JASI_107_19","volume":"69","author":"B Singh","year":"2020","unstructured":"Singh B, Bose P, Shamal SN, Joshi D, Singh R (2020) Polymorphic study of ataxin 3 gene in eastern Uttar Pradesh population. J Anatom Soc India 69(4):226\u2013232","journal-title":"J Anatom Soc India"},{"issue":"2","key":"12829_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1086\/318184","volume":"68","author":"C Gaspar","year":"2001","unstructured":"Gaspar C, Lopes-Cendes I, Hayes S, Goto J, Arvidsson K, Dias A et al (2001) Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet 68(2):523\u2013528","journal-title":"Am J Hum Genet"},{"issue":"8","key":"12829_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134405","volume":"10","author":"SR Gan","year":"2015","unstructured":"Gan SR, Ni W, Dong Y, Wang N, Wu ZY (2015) Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population. PLoS\u00a0One 10(8):e0134405","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"12829_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jmoldx.2020.03.003","volume":"22","author":"SM Lopes","year":"2020","unstructured":"Lopes SM, Faro R, Lopes MM, Onofre I, Mendon\u00e7a N, Ribeiro J et al (2020) Protocol for the characterization of the Cytosine-Adenine-Guanine tract and flanking polymorphisms in Machado-Joseph Disease: impact on diagnosis and development of gene-based therapies. J Mol Diagn 22(6):782\u2013793","journal-title":"J Mol Diagn"},{"issue":"10","key":"12829_CR24","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1001\/archneur.64.10.1502","volume":"64","author":"S Martins","year":"2007","unstructured":"Martins S, Calafell F, Gaspar C, Wong VC, Silveira I, Nicholson GA et al (2007) Asian origin for the worldwide-spread mutational event in Machado-Joseph disease. Arch Neurol 64(10):1502\u20131508","journal-title":"Arch Neurol"},{"issue":"6","key":"12829_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archneurol.2011.2504","volume":"69","author":"S Martins","year":"2012","unstructured":"Martins S, Soong BW, Wong VC, Giunti P, Stevanin G, Ranum LP et al (2012) Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. Arch Neurol 69(6):746\u2013751","journal-title":"Arch Neurol"},{"key":"12829_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb7086","author":"M Prudencio","year":"2020","unstructured":"Prudencio M, Garcia-Moreno H, Jansen-West KR, Al-Shaikh RH, Gendron TF, Heckman MG et al (2020) Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abb7086","journal-title":"Sci Transl Med"},{"issue":"2","key":"12829_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12892","volume":"49","author":"MM Santana","year":"2023","unstructured":"Santana MM, Gaspar LS, Pinto MM, Silva P, Adao D, Pereira D et al (2023) A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia. Neuropathol Appl Neurobiol 49(2):e12892","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"12829_CR28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717\u20131720","journal-title":"Neurology"},{"issue":"3","key":"12829_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","volume":"12","author":"H Jacobi","year":"2013","unstructured":"Jacobi H, Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P et al (2013) Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum 12(3):418\u2013428","journal-title":"Cerebellum"},{"issue":"7","key":"12829_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jmedgenet-2013-102200","volume":"51","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel S, Durr A, Rakowicz M, Nanetti L, Charles P, Sulek A et al (2014) Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet 51(7):479\u2013486","journal-title":"J Med Genet"},{"issue":"2","key":"12829_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1074\/jbc.RA118.005801","volume":"294","author":"D Weish\u00e4upl","year":"2009","unstructured":"Weish\u00e4upl D, Schneider J, Peixoto Pinheiro B, Ruess C, Dold SM, von Zweydorf F, et al (2019) Physiological and pathophysiological characteristics of ataxin-3 isoforms. J Biol Chem 294(2):644\u201361","journal-title":"J Biol Chem"},{"key":"12829_CR32","doi-asserted-by":"crossref","unstructured":"Raposo M, H\u00fcbener-Schmid J, Tagett R, Ferreira AF, Melo ARV, Vasconcelos J, et al. Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3\/Machado-Joseph disease. bioRxiv. 2023:2023.04.22.537936","DOI":"10.1101\/2023.04.22.537936"},{"issue":"1","key":"12829_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","volume":"95","author":"CA Matos","year":"2011","unstructured":"Matos CA, de Macedo-Ribeiro S, Carvalho AL (2011) Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog Neurobiol 95(1):26\u201348","journal-title":"Prog Neurobiol"},{"issue":"6","key":"12829_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke ST, Baker BF, Crooke RM, Liang X-H (2021) Antisense technology: an overview and prospectus. Nat Rev Drug Discov 20(6):427\u2013453","journal-title":"Nat Rev Drug Discov"},{"issue":"7228","key":"12829_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature07754","volume":"457","author":"H Siomi","year":"2009","unstructured":"Siomi H, Siomi MC (2009) On the road to reading the RNA-interference code. Nature 457(7228):396\u2013404","journal-title":"Nature"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12829-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T05:09:09Z","timestamp":1766725749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12829-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12829"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12829-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the local ethics committees of all participating centers. Informed and written consent was obtained from all study participants at enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"54"}}